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Background: Schmallenberg virus (SBV) is a member of the Orthobunyavirus genus (Bunyaviridae family) causing
malformations and abortions in ruminants. Although, as for other members of this family/genus, the non-structural
protein NSs has been shown to be an interferon antagonist, very little is known regarding the overall inhibitory
effects and targets of orthobunyavirus NSs proteins on host gene expression during infection. Therefore, using
RNA-seq this study describes changes to the transcriptome of primary bovine cells following infection with
Schmallenberg virus (SBV) or with a mutant lacking the non-structural protein NSs (SBVdelNSs) providing a detailed
comparison of the effect of NSs expression on the host cell.
Results: The sequence reads from all samples (uninfected cells, SBV and SBVdelNSs) assembled well to the bovine
host reference genome (on average 87.43% of the reads). During infection with SBVdelNSs, 649 genes were
differentially expressed compared to uninfected cells (78.7% upregulated) and many of these were known antiviral
and IFN-stimulated genes. On the other hand, only nine genes were differentially expressed in SBV infected cells
compared to uninfected control cells, demonstrating the strong inhibitory effect of NSs on cellular gene expression.
However, the majority of the genes that were expressed during SBV infection are involved in restriction of viral
replication and spread indicating that SBV does not completely manage to shutdown the host antiviral response.
Conclusions: In this study we show the effects of SBV NSs on the transcriptome of infected cells as well as the
cellular response to wild type SBV. Although NSs is very efficient in shutting down genes of the host innate
response, a number of possible antiviral factors were identified. Thus the data from this study can serve as a base
for more detailed mechanistic studies of SBV and other orthobunyaviruses.
Keywords: Schmallenberg virus, Orthobunyavirus, RNA-seq, Transcriptome, Antiviral response, Non-structural
protein NSsBackground
Schmallenberg virus (SBV) is a negative-sense, single-
stranded, segmented, RNA virus belonging to the Bunya-
viridae family, within the genus Orthobunyavirus. The
virus was discovered 2011 in connection with outbreaks
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unless otherwise stated.in Germany and the Netherlands [1] and has since the ini-
tial discovery rapidly spread to many European countries
[2]. Although infection is often connected with milder
symptoms it can cause foetal abortions and malformations
in ruminants [1,3]. SBV was the first orthobunyavirus
detected in Europe, but the genus consists of over 170 vi-
ruses grouped into 18 serogroups and many of these are
important pathogens. In humans, this includes for ex-
ample La Crosse virus (LACV) causing encephalitis and
Ngari Virus causing haermorrhagic fever [4]. Animal path-
ogens, apart from SBV, includes Akabane virus (AKBV)tral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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and can cause abortions and congenital malformations.
The SBV genome consists of three segments (L, large; M,
medium; and S, small) coding for four structural proteins
(N, nucleoprotein; Gn and Gc, glycoproteins; L, RNA-
dependent RNA polymerase) and two non-structural
proteins (NSm and NSs). Through the production of re-
combinant viruses lacking NSs (LACVdelNSs, AKBV-
delNSs and Bunyamwera(BUNV)delNSs), NSs has been
shown to be a major virulence factor for orthobunya-
viruses as these deletant viruses are attenuated and
show reduced growth rate compared to wild type virus
[5-7]. SBV NSs has also been shown to be able to counter-
act host antiviral responses. Recombinant SBV lacking
ability to express NSs (SBVdelNSs) is a potent inducer of
type I IFN while SBV does not induce the IFN response
after infection [8,9]. Apart from interfering with the IFN
pathway, SBV NSs has also been shown to induce deg-
radation of the RPB1 subunit of RNA polymerase II and
to potentially have a pro-apoptotic role [10]. However,
little is known about the overall inhibitory effects and
targets of orthobunyavirus NSs proteins on gene expres-
sion in infected cells. Therefore, in this study we ana-
lysed the changes in the transcriptome of primaryFigure 1 Infection of SBV and SBVdelNSs in bovine primary cells. (A) Immu
cells 16 h post infection (p.i.) showed about 30% infection rate. (B) Westernbovine cells following infection with either wild type
SBV or SBVdelNSs (5, 6).
Results and discussion
Viral infection and sequencing output – quality and
reference assembly
We carried out RNA-seq analysis in infected and mock-
infected primary bovine cells, in order to use cells with
an intact cell-autonomous innate immune system. Bo-
vine primary fibroblasts were infected with either SBV,
SBVdelNSs or mock-infected and RNA was extracted at
16 h p.i.. Three biological replicates were assesses for each
sample and cells were also infected in parallel for immuno-
fluorescence (Figure 1A) and Western blot (Figure 1B) in
order to confirm that the bovine primary cells were in-
fected by SBV and SBVdelNSs at 16 h. Both the SBV and
the SBVdelNSs infected cells were positive for the virus
with an estimated infection rate at about 30%.
The samples for transcriptome analysis were sequenced
on Illumina MiSeq. On average, 26.5 million reads/sample
were generated with a phred quality value of 30 or higher
and 87.43% of the sequence reads assembled against
the Bos taurus genome (Ensembl Btau_4.0) using
TopHat2 [11]. mRNA enrichment was carried out priornofluorescent detection (N protein) of SBV and SBVdelNSs infected
blot analysis of SBV N protein and γ-tubulin at 16 h p.i.
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SBV) lack a poly-A tail in their genome and mRNAs,
consequently no assembly against the virus genome
was performed.
Differential expression analysis
Cuffdiff2 [12] was used to identify differentially expressed
(DE) genes (genes with a +/− 2-fold change or more and
with p ≤ 0.05 were considered significant). 651 DE genes
were identified and most were found in the SBVdelNSs in-
fected cells (Figure 2A). Hence, the majority of the DE
genes are as a direct or indirect result of the loss of NSs.
Most (78.7%) of the DE genes affected by the loss of NSs
were upregulated and fold differences ranged from 12.7-
fold to the 1-fold cut-off value (on a log2 scale). The fold
changes for down-regulated genes (21.3%) were more
subtle, ranging from 2.72-fold to the 1-fold cut-off (log2
scale). The DE sequence analysis was validated for 10
genes using Sybr green realtime PCR (Figure 2B); the
fold changes for SBVdelNSs compared to the SBV in-
fected cells were all significant (p ≤ 0.05) and corre-
sponded to the sequencing data.
Pathway analysis
Ingenuity Pathway Analysis (IPA) (http://www.ingenuity.
com/products/ipa) showed that the DE genes are, to a
great extent, involved in pathways associated with host
antiviral responses (Table 1), such as type I IFN-signalling
and IFN-dependent gene expression, as well as pattern
recognition. This is also evident when extracting the top
30 most upregulated genes (Table 2) as most of these have
antiviral functions. The major molecules involved in viralFigure 2 Analysis of differentially expressed (DE) genes 16 h p.i. (A) Venn d
transcript level changes detected in the RNA-seq DE analysis. For all genes
between SBVdelNSs infection and SBV infected cells.RNA recognition including DDX58 (RIG-I), TRIM25,
IFIH1 (MDA5), PKR, TLR3 were highly up-regulated in
SBVdelNSs infected cells (Figure 3A), as are those in-
volved in antigen presentation to CD8+ T-lymphocytes
including MHC I α/β and TAP 1/2 (Figure 3B). As a con-
sequence of activation of the viral RNA recognition path-
ways many interferon stimulated genes such OAS1/2,
MX1 and several guanylate binding proteins, were upreg-
ulated [13-16]. Several interleukins were found among the
DE transcripts, for example IL-8 and its downstream mol-
ecules (e.g. VCAM-1, ICAM-1 and Cox2) involved in
inflammation, activation of angiogenesis and leucocyte in-
filtration/activation (Figure 3B).
In SBV-infected cells only nine DE genes (RSAD2,
ISG15, OAS1, OAS2, IFIT2, MX1, GNAL, RPS3A and
MDFI) were identified (eight upregulated and one down-
regulated) (Figure 2A and Table 1). The majority of these
genes are involved in antiviral responses. All up-regulated
genes in SBV infected cells, except guanine nucleotide
binding protein (G protein), alpha activating activity poly-
peptide, olfactory type (GNAL) and ribosomal protein
S3A (RPS3A), were also upregulated following SBVdelNSs
infection, although to a much higher extent, indicating
that NSs may not be able to completely shutdown all
genes of the host antiviral response. Viperin (RSAD2) can
be induced by a number of different viruses such as sind-
bis virus, Japanese encephalitis virus and lassa fever virus
(LASV) either dependently and independently of IFN [17].
For example, Zapata JC et al. [18] showed that LASV
strongly induce viperin early in infection (PBMC) while
the attenuated ML29 has a weaker and delayed viperin
induction suggesting that ML29 has a mechanism toiagram of the DE genes. (B) Quantitative PCR confirmation of
there is a significant statistical difference (p≤ 0.05) in gene expression
Table 1 Canonical pathway associated with infection of Schmallenberg virus or a mutant lacking NSs
SBV vs uninfected
Ingenuity canonical pathways -log(p-value) Ratio Genes
Interferon Signaling 3.96E00 5.56E-02 OAS1,MX1
Activation of IRF by Cytosolic Pattern
Recognition Receptors
3.42E00 2.74E-02 IFIT2,ISG15
Role of Pattern Recognition Receptors in
Recognition of Bacteria and Viruses
3.06E00 1.83E-02 OAS1,OAS2
Role of Lipids/Lipid Rafts in the Pathogenesis
of Influenza
1.95E00 3.45E-02 RSAD2
Ephrin B Signaling 1.47E00 1.22E-02 GNAL
CDK5 Signaling 1.39E00 1.03E-02 GNAL
G Beta Gamma Signaling 1.39E00 8.26E-03 GNAL
IL-1 Signaling 1.37E00 9.17E-03 GNAL
Androgen Signaling 1.29E00 6.9E-03 GNAL
Relaxin Signaling 1.2E00 6.1E-03 GNAL
SBVdelNSs vs uninfected
Ingenuity Canonical Pathways -log(p-value) Ratio Genes
Interferon Signaling 9.77E00 3.33E-01 IFIT3,SOCS1,IFIT1,OAS1,MX1,IFI35,STAT2,IRF9,PSMB8,JAK2,
TAP1,IRF1




Role of Pattern Recognition Receptors in
Recognition of Bacteria and Viruses
8.35E00 1.56E-01 OAS1,PRKCQ,C3,OAS2,IL6,CCL5,IRF3,NFKB1,RNASEL,TLR2,
IFIH1,TLR4,DDX58,EIF2AK2,TLR3,RIPK2,ATM
NF-κB Signaling 7.81E00 1.22E-01 AZI2,PRKCQ,RELB,IL36A,TNFAIP3,TBK1,IRAK3,NFKB1,TLR2,
TLR4,TNIP1,NFKBIA,CD40,NGFR,MAP3K8,TRAF5,EIF2AK2,
TLR3,NFKBIB,CASP8,ATM,TNFRSF11B
Role of Macrophages, Fibroblasts and





Dendritic Cell Maturation 7.58E00 1.04E-01 B2M,ICAM1,HLA-A,RELB,IL15,IL36A,HLA-DMB,IL6,JAK2,
NFKB1,FCGR1A,TLR2,TLR4,NFKBIA,CD40,NGFR,STAT2,
TLR3,NFKBIB,IL23A,ATM,TNFRSF11B
Antigen Presentation Pathway 6.97E00 2.38E-01 B2M,PSMB9,NLRC5,HLA-A,HLA-DMB,PSMB8,TAP1,TAP2,
TAPBP,MR1




LXR/RXR Activation 6.08E00 1.15E-01 C3,IL1RL1,IL36A,IRF3,IL6,NFKB1,ABCA1,TLR4,CCL2,NGFR,
MYLIP,LPL,CD14,PTGS2,TLR3,TNFRSF11B
Hepatic Fibrosis/Hepatic Stellate Cell Activation 5.93E00 1.1E-01 IL8,VCAM1,ICAM1,IL1RL1,IGFBP5,IL6,CCL5,NFKB1,TLR4,
CD40,CCL2,CSF1,HGF,NGFR,TGFB2,CD14,TNFRSF11B
This table shows the top 10 IPA canonical pathways associated with SBV and SBVdelNSs infection, the p-value of Fisher’s exact test, the ratio (number of the genes
in the dataset mapping to each specific pathway divided by the total number of genes in the pathway) and lists the DE genes from this study involved in
respective pathway.
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Antiviral activity of RSAD2 has been shown against for
example BUNV, chikungunya virus, influenza virus and
dengue virus through different mechanisms such as inhib-
ition of viral replication and budding/egress [13-16,19].
MX1 has also been shown to have antiviral activity against
a number of different RNA viruses such influenza and
bunyaviruses [20]. MX1 is significantly upregulated in foe-
tuses infected with CVV and it has been proposed to beinvolved in the clearance of the virus [21]. During LACV
infection MX1 can bind to the nucleocapsid and inhibit
viral replication [22]. Also, ISG15 is upregulated during
foetal infection with CVV [21]. The OAS proteins per-
forms their antiviral activity through the activation of
RNAseL which leads to degradation of cellular and viral
RNA [23] and OAS1, but not OAS2, is reported to con-
tribute to a slight inhibition of BUNV and BUNVdelNSs
viruses [19]. Hence although very few genes were up
Table 2 Up-regulated genes in SBV or SBVdelNSs infected cells
Top up-regulated genes
Symbol Entrez gene name Fold change (log2)
SBV delNSsSBV
RSAD2 radical S-adenosyl methionine domain containing 2 1.96 11.518
ISG15 ISG15 ubiquitin-like modifier 1.86 10.886
IFIH1/MDA5 interferon induced with helicase C domain 1 - 9.987
GBP5 guanylate binding protein 5 - 9.837
OAS1 2′-5′-oligoadenylate synthetase 1, 40/46 kDa 2.24 9.818
IFIT2 interferon-induced protein with tetratricopeptide repeats 2 1.06 9.643
IFI27 interferon, alpha-inducible protein 27 - 9.387
ZBP1 Z-DNA binding protein 1 - 9.372
GBP4 guanylate binding protein 4 - 9.354
VCAM1 vascular cell adhesion molecule 1 - 9.287
OAS2 2′-5′-oligoadenylate synthetase 2, 69/71 kDa 2.41 9,.064
IFIT3 interferon-induced protein with tetratricopeptide repeats 3 - 8.87
MX1 myxovirus (influenza virus) resistance 1, 1.45 8.683
XAF1 XIAP associated factor 1 - 8.264
CCL5 chemokine (C-C motif) ligand 5 - 8.081
RTP4 receptor (chemosensory) transporter protein 4 - 8.059
GBP1 guanylate binding protein 1, interferon-inducible - 7.483
GBP2 guanylate binding protein 2, interferon-inducible - 6.853
LGALS9 lectin, galactoside-binding, soluble, 9 - 6.571
USP18 ubiquitin specific peptidase 18 - 6.536
CMPK2 cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial - 6.52
UBA7 ubiquitin-like modifier activating enzyme 7 - 6.15
DDX58 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 - 6.022
CXCL2 chemokine (C-X-C motif) ligand 2 - 5.946
CYP2J2 cytochrome P450, family 2, subfamily J, polypeptide 2 - 5.936
IFI6 interferon, alpha-inducible protein 6 - 5.807
MCHR1 melanin-concentrating hormone receptor 1 - 5.762
IFIT1 interferon-induced protein with tetratricopeptide repeats 1 - 5.681
HERC6 HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 - 5.612
BATF2 basic leucine zipper transcription factor, ATF-like 2 - 5.483
GNAL Guanine nucleotide-binding protein G(olf) subunit alpha 1.37 -
RPS3A ribosomal protein S3A 1.16 -
The table indicates the most up-regulated genes during SBV and SBVdelNSs infection of bovine primary cells at 16 h (compared to uninfected cells). The fold-
change is shown in log2 and “-” denotes no fold-change.
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genes have all been previously shown to have antiviral ac-
tivity for other similar viruses indicating that these genes,
individually or collectively, may have an important role in
the antiviral response and the consequent restriction of
SBV infection. However, it should be noted that we only
investigated host responses at one time point, and it is
possible that at an earlier or later time point during the
viral replication cycle, more DE genes may be found, as
shown for dengue virus for example [24,25]. As not allprimary cells were infected by SBV or SBVdelNSs it is
possible that weak host responses to SBV might be
masked by transcripts from uninfected cells. This may also
explain why the DE analysis of SBV infected cells did not
show a general host transcription shutdown as described
[10], although mRNA turnover and cell types used in
this and other studies may be further reasons. Only one
transcript (MDFI – MyoD family inhibitor) was down-
regulated in SBV infected cells compared to uninfected
cells. This gene was also down-regulated in SBVdelNSs-
Figure 3 Schematic overview of some of the most significant IPA-identified, canonical host response pathways. (A) Role of pattern recognition
pathways and the interferon signaling pathway. (B) Antigen presentation pathways and pathways involved in leukocyte recruitment and IL-8
signaling. Red boxes are genes upregulated in SBVdelNSs compared to uninfected cells; white boxes are genes not differentially expressed.
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the NSs protein alone. This is a transcription factor that
negatively regulates myogenic proteins. Knockout stud-
ies of the murine homolog, inhibitory of myogenic fam-
ily (l-mfa), have shown that lack of l-mfa can lead to
embryonic lethality and placental defects as well as
skeletal patterning defects [26]. Although, the high viral
levels of SBV seen in brain tissue are likely to cause the
teratogenic effects seen during SBV infection the down-
regulation of MDFI in SBV and SBVdelNSs infected
cells is potentially of interest in relation to foetal abnor-
malities linked to SBV infection. Future studies will de-
termine whether SBV and SBVdelINSs affect expression
of MDFI in fetal brain tissue.Conclusions
We have investigated the effect of SBV infection on the
host transcriptome and more specifically the effects in-
duced by lack of NSs expression. Our results show the
response to orthobunyavirus infection in a relevant host
cell system and that NSs is very efficient in shutting down
the immune response of the host but that despite this a
number of known antiviral proteins (such as viperin,
MX1, OAS1/2 etc.) are still induced during SBV infection.
The data from this study serves to identify possible anti-
viral factors and serve as a basis for more detailed mech-
anistic studies of SBV and other orthobunyaviruses as well
as the mechanism(s) of action of their NSs protein.Methods
Cells
Bovine fibroblast cells were isolated from cow aortas by col-
lagenase treatment using a method adapted described earl-
ier [27]. Aortas were harvested from killed animals sourced
from an abattoir and incubated at room temperature for
3 h in Dulbecco’s modified Eagles medium (DMEM) (Life
Technologies) supplemented with 5 % foetal bovine serum
(FBS), 100 U/ml penicillin 100 μg/ml streptomycin (P/S)
and 2.5 μg/ml amphotericin B. After incubation, the aortas
were cleaned, opened longitudinally and placed, intima
layer down, into collagenase (2 mg/ml, DMEM) for
60 min at 37°C. After incubation the cells were isolated by
collection of the collagenase supernatant and scraping of
the aorta wall that was in contact with the collagenase.
The supernatant containing the cells was centrifuged at
1000 rpm for 5 mins. The cells were then resuspended,
seeded in 12-well plates and maintained at 37°C and 5%
CO2 in DMEM with 20% FBS, 100 U/ml penicillin
100 μg/ml Streptomycin, 2.5 μg/ml amphotericin B. The
population was initially a mixture of endothelial cells
and fibroblasts but frequent passaging for approximately
10 days allowed the fibroblasts to outgrow the endothelial
cells and form a pure population of fibroblasts.Viruses and infections
Rescued wild type SBV as well as a SBV lacking NSs
described in Elliot et al. [8] were used throughout all the
experiments.
Bovine fibroblasts were seeded in 24-well plates and at
a confluence of 80% the cells were infected with SBV or
SBVdelNSs at a MOI of 5 for 16 h. Mock-infected cells
were included in parallel as control. For each condition
three individual replicates were set up. Viral infection
was confirmed by immunofluorescence and western blot
targeting the N-protein of the virus. For western blot γ-
tubulin (Sigma) was used as an internal control.
RNA extraction
RNA was extracted from infected and uninfected cells
using a combination of Trizol (Life Technology) and
RNeasy Mini kit (Qiagen). In short, the cell media was
discarded from the wells and the cells were mixed and
homogenised in 750 μl Trizol. Chloroform (150 μl) was
added and the sample mixed prior to a short incubation
at room temperature and a centrifugation step at +4°C
for 15 minutes. The upper aqueous phase was trans-
ferred to a new tube and mixed with 70% EtOH and
then transferred to a RNeasy Mini Spin Column. The
sample was bound to the column through centrifugation
and then washed once with RW1 buffer and twice with
RPE-buffer before eluted with 30 μl RNase free water.
The RNA was stored at −80°C until further use.
Library preparation and MiSeq sequencing
The TruSeq stranded mRNA sample preparation kit
(Illumina) was used to enrich samples for mRNA and
construct libraries for sequencing. Single end datasets
with a read length of 150 nucleotides were generated from
each sample library on an Illumina MiSeq. Each sample
(SBV, SBVdelNSs and uninfected control) was set up in
triplicate, and sequenced on a separate MiSeq run, with 9
runs being carried out in total. The sequences from the
MiSeq runs have been deposited in the European Nucleo-
tide Archive (ENA) and can be accessed through the study
accession number PRJEB9007.
Sequence quality and assembly
The FastQC software (http://www.bioinformatics.babra
ham.ac.uk/projects/fastqc) was used to check the RNA-
Seq reads quality in order to remove low quality reads
(Q > 30). The reads that passed the quality check were
assembled against the Bos taurus genome (Ensembl
Btau_4.0) using TopHat2 [11].
Differential expression and pathway analysis
Cuffdiff2 within the Cufflink package (v2.2.1) [12] was
used to identify differentially expressed (DE) genes and
genes with a +/− 2-fold change or more and with p ≤ 0.05
Blomström et al. BMC Genomics  (2015) 16:324 Page 8 of 8were considered significant and used in the further analysis.
Ingenuity Pathway Analysis (IPA) (http://www.ingenuity.
com/products/ipa) was applied for the functional annota-
tion and pathway analysis.
Realtime PCR verification
150 ng RNA were converted into cDNA using superscript
(Life Technologies) with 150 ng oligo(dT) (Promega) ac-
cording to the manufacturer’s instructions. Fast SYBR
Green Master mix (Life Technologies) was run according
to the manufacturer’s protocol, primers are available
on request. GAPDH was used as a housekeeping gene
and the expression fold-changes was calculated using
the 2-ΔΔCt method.
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